MRK

HOLD

Merck & Company, Inc.

Healthcare · Rank #5 · Analyzed Apr 20, 2026

$119.07

Current Price

$264.25

Intrinsic Value

0.0%

Upside/Downside

10/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus2/3 methods agree

Quality Score4/5.0

Framework RatingHOLD

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$17.06

Base (IV)$264.25

High$409.43

Entry Points

Conservative$17.06

Moderate$140.65

Aggressive$264.25

⚠️ Warnings

Upside capped: raw 244% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity36.9% → 1.0/1.0

Debt LevelD/E 96 → 0/1.0

Revenue QualityGrowth 7.8%, margin Δ-25.5% +recovery → 1.0/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins28.1% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.